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Abstract: The correct amino acid sequence of E. coli isoleucyl-tRNA synthetase (IleRS) was established by means of 
peptide mapping by MALDI mass spectrometry, using a set of four endoproteases (trypsin, LysC, AspN and GluC). 
Thereafter, the active site of IleRS was mapped by affinity labeling with reactive analogs of the substrates. For the ATP 
binding site, the affinity labeling reagent was pyridoxal 5'-diphospho-5'-adenosine (ADP-PL), whereas periodate-oxidized 
tRNA
Ile, the 2',3'-dialdehyde derivative of tRNA
Ile was used to label the binding site for the 3'-end of tRNA on the syn-
thetase. Incubation of either reagent with IleRS resulted in a rapid loss of both the tRNA
Ile aminoacylation and isoleucine-
dependent isotopic ATP-PPi exchange activities. The stoichiometries of IleRS labeling by ADP-PL or tRNA
Ileox corre-
sponded to 1 mol of reagent incorporated per mol of enzyme. Altogether, the oxidized 3'-end of tRNA
Ile and the pyridoxal 
moiety of the ATP analog ADP-PL react with the lysyl residues 601 and 604 of the consensus sequence 
601KMSKS
605. 
Identification of the binding site for L-isoleucine or for non cognate amino acids on E. coli IleRS was achieved by qualita-
tive comparative labeling of the synthetase with bromomethyl ketone derivatives of L-isoleucine (IBMK) or of the non-
cognate amino acids valine (VBMK), phenylalanine (FBMK) and norleucine (NleBMK). Labeling of the enzyme with 
IBMK resulted in a complete loss of isoleucine-dependent isotopic [
32P]PPi-ATP exchange activity. VBMK, NleBMK 
and FBMK were also capable of abolishing the activity of IleRS, FBMK being the less efficient in inactivating the syn-
thetase. Analysis by MALDI mass spectrometry designated cysteines-462 and -718 as the target residues of the substrate 
analog IBMK on E. coli IleRS, whereas VBMK, NleBMK and FBMK labeled in common His-394, His-478 and Cys-718. 
In addition, VBMK and NleBMK, which are chemically similar to IBMK, were found covalently bound to Cys-462, and 
VBMK was specifically attached to His-332 (or His-337) of the synthetase. The amino acid residues labeled by the sub-
strate analogs are mainly distributed between three regions in the primary structure of E. coli IleRS: these are segments 
[325-394], [451-479] and [591-604]. In the 3-D structures of IleRS from T. thermophilus and S. aureus, the [325-394] 
stretch is part of the editing domain, while fragments [451-479] and [591-604] representing the isoleucine binding domain 
and the dinucleotide (or Rossmann) fold domain, respectively, are located in the catalytic core. His-332 of E. coli IleRS, 
that is strictly conserved among all the available IleRS sequences is located in the editing active site of the synthetase. It is 
proposed that His-332 of E. coli IleRS participates directly in hydrolysis, or helps to deprotonate the hydroxyl group of 
threonine at the hydrolytic site. 
INTRODUCTION 
  Aminoacyl-tRNA synthetases catalyze at the expense of 
ATP the activation of specific amino acids, and their subse-
quent transfer onto the 3'-end of homologous isoacceptor 
tRNAs. The specific recognition of tRNAs by aminoacyl-
tRNA synthetases makes these enzymes attractive model 
systems for studying protein-nucleic acid interaction. To 
probe the structure-activity relationships of aminoacyl-tRNA  
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synthetases, chemical modification of these enzymes with 
reactive analogs of the substrates has been used. Lysyl resi-
dues at the binding site for the 3'-OH acceptor arm of tRNA 
were identified by affinity labeling with periodate-oxidized 
tRNA [1-5], leading to the discovery of the KMSKS consen-
sus sequence [3, 4, 6] characteristic of class 1 aminoacyl-
tRNA synthetases. Amino acid residues at the ATP-binding 
site of aminoacyl-tRNA synthetases were affinity labeled 
with ATP derivatives such as adenosine di- or triphos-
phopyridoxal or 5'-p-fluorosulfonyl-benzoyladenosine [7-9]. 
Pyridoxal 5'-phosphate and pyridoxal 5'-diphosphate have 
also been used to identify the subsite for the pyrophosphate 
moiety or for the -phosphate of ATP [10, 11]. Nucleophilic 
amino acid residues at the binding site for L-valine or for 
non-cognate amino acids were identified by comparative 
labeling of valyl-tRNA synthetase (ValRS) with bro-Binding Site for tRNA
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momethylketone derivatives [12]. The latter site referred to 
as the editing site is responsible for the Val/Thr editing activ-
ity of E. coli ValRS which prevents attachment of L-
threonine to tRNA
Val [13]. 
  In the present work, we have applied this labeling strat-
egy to E.coli  isoleucyl-tRNA synthetase (IleRS), a mono-
meric synthetase with Ile/Val editing activity [14]. Reactive 
substrate analogs were used to identify amino acid residues 
at the binding site for tRNA, ATP and L-isoleucine or for 
non cognate amino acids on this synthetase. Lysyl residues 
of IleRS at the binding site for the CCA arm of tRNA have 
been affinity labeled by periodate-oxidized tRNA
Ile. In the 
case of the ATP-binding site, the affinity labeling reagent 
used was pyridoxal 5'-diphospho-5'-adenosine (or adenosine 
diphosphopyridoxal, ADP-PL), an adenine nucleotide analog 
with an adenosine diphosphate moiety and a pyridoxal moi-
ety capable of covalently modifying amino groups in or near 
the phosphate binding site. The aminoacyl-tRNA synthetases 
such as IleRS or ValRS which are concerned with editing are 
believed to exhibit two catalytic sites, one for aminoacyla-
tion with the cognate amino acid, and one for editing of 
misactivated non-cognate amino acids. In order to identify 
those sites on IleRS, bromomethyl ketone derivatives of the 
substrate L-isoleucine (IBMK) or of non-cognate amino ac-
ids valine (VBMK), phenylalanine (FBMK) and norleucine 
(NleBMK), were used for qualitative comparative labeling of 
E. coli IleRS (Fig. 1). Bromomethyl ketone derivatives react 
preferentially with cysteine and histidine residues, and 
weakly with lysines and tyrosines. Since nucleophilic side 
chains are expected to be involved in the hydrolytic process 
at the editing site of the aminoacyl-tRNA synthetases con-
cerned with editing, a bromomethyl moiety tethered to the 
carbonyl group of valine, norleucine or phenylalanine should 
be well situated for modification of nucleophiles at the hy-
drolytic site of IleRS, while the substrate analog isoleucine 
bromomethyl ketone would react with amino acid residues 
present in the binding site for L-isoleucine. The location of 
residues labeled by the markers is discussed on the basis of 
the 3-D structures of IleRS from Thermus thermophilus and 
Staphylococcus aureus [15, 16]. Indeed, the crystal struc-
tures at 2.5 Å resolution of IleRS from T. thermophilus in 
complexes with L-isoleucine and L-valine were previously 
reported [15], as well as that at 2.2 Å resolution of S. aureus 
IleRS complexed with tRNA
Ile
 and mupirocin [16]. 
 
 
 
 
 
 
 
 
Fig. (1). Structure of amino acid analogs used to label IleRS.  
 
  Prior to these labeling experiments, it was necessary to 
establish a valid primary structure of E. coli IleRS, because 
two different sequences had been retrieved from literature 
and data bases [17-19]. The correct sequence of IleRS was 
determined by fast peptide mapping, using a set of four dif-
ferent proteases to generate peptides that were identified by 
means of matrix assisted laser desorption-ionisation–mass 
spectrometry (MALDI-MS) [20]. 
MATERIALS AND METHODS 
Materials 
  Isoleucyl-tRNA synthetase from E. coli strain EM20031 
was purified as described [21]. The molar concentration of 
the synthetase was calculated from its absorbancy at 280 nm 
and from the following values of molecular ratio and of opti-
cal extinction coefficient deduced from amino acid composi-
tion: 105 K and 1.7 units.mg
-1.cm
2. tRNA
Ile (0.8 nmol of 
isoleucine acceptance/A260 unit of tRNA) was from Subriden 
RNA (Washington, DC). Unfractionated tRNA was obtained 
from the pilot facilities of the Institut de Chimie des Sub-
stances Naturelles du CNRS (Gif-sur–Yvette, France). tRNA 
concentration was calculated according to its specific absorp-
tion coefficient at 260 nm [22]. [
14C]ATP (450 Ci/mol) was 
from the Commissariat à l’Energie Atomique (Saclay, 
France).  
  Sequence grade TosPheCH2Cl-treated trypsin and endo-
proteases LysC, GluC and AspN were from Roche Diagnos-
tics (Meylan, France). N-(2-hydroxyethyl)piperazine-N’-2-
ethanesulfonic acid (Hepes), phenylmethanesulfonyl fluo-
ride, ribonuclease-free -chymotrypsin, pancreatic ribonu-
clease (RNAse A) and diethyl pyrocarbonate (DEPC) were 
from Sigma. Matrix solutions and peptide standards for 
MALDI-MS analyses were also from Sigma. Acetonitrile 
(HPLC grade) was from Baker Chemical Company. All 
other reagents were the highest grade available. 
Methods 
Preparation of [
14C]tRNA
Ile 
  A sample of unfractionated E. coli tRNA (16.5 mg) con-
taining 3% of isoleucine-specific tRNA was incubated for 15 
min at 25°C with 2 μM of IleRS from E. coli and 2 mM of 
L-isoleucine, in 5 mL of 20 mM Tris-HCl (pH 7.5) contain-
ing 2 mM ATP, 7 mM MgCl2 and 150 mM KCl. It was veri-
fied that, in these conditions, the 3% of tRNA
Ile present in 
the incubation mixture were completely charged with L-
isoleucine. The sample was then incubated 30 min at room 
temperature, in the dark, in the presence of 10 mM NaIO4. 
As a consequence of the latter treatment, only the non-
specific tRNAs which were not aminacylated with isoleucine 
by IleRS, were expected to be oxidized to a dialdehyde 
group on the 3'-terminal ribose. Further treatment of the mix-
ture with 25 mM sodium borohydride provoked the reduc-
tion of the oxidized tRNAs (tRNAox) to yield tRNAox-red, 
tRNA molecules with primary alcohol groups (CH2OH) at 
the positions 2' and 3' of the ribose. Actually, these tRNAox-
red species, which are not specific for isoleucine, are not 
concerned with further chemical modifications, because pri-
mary alcohol groups are non-reactive in the tRNA modifica-
tion conditions used. The tRNA molecules specific for L-
isoleucine, and which were charged with this amino acid in 
the presence of IleRS, were then deacylated as follows: the 
NaBH4-treated tRNA sample was precipitated by the addi-
tion of 0.2 volume of 5 M NaCl and 2.2 volumes of cold 
ethanol. After centrifugation, the pellet was dissolved in 5 
mL of Tris-HCl 2 M (pH 9.0) and left 2h at 37°C. As a con-
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sequence of the latter treatment, the isoleucyl-tRNA
Ile spe-
cies was stripped and the sample was ethanol precipitated as 
above. Removal of the 3'-terminal adenosine from the 3'-OH 
end of tRNA
Ile was achieved by combining periodate, lysine 
and alkaline phosphatase treatments, as already described 
[23]. The resulting tRNA
Ile molecules, shortened by one nu-
cleotide at the 3'-end, were repaired with the help of tRNA 
nucleotidyl-transferase in the presence of [
14C]ATP (9 
Ci/mol) and assayed for their recovery of isoleucylation ca-
pacity, as previously described [23]. After nucleotide incor-
poration, the tRNA sample (including the reconstituted 
[
14C]tRNA
Ile species) was separated from the excess of 
[
14C]ATP by chromatography on a Sephadex G-50 column 
equilibrated with 1 mM potassium acetate buffer (pH 5.5) 
containing 0.1 mM MgCl2. The tRNA was then precipitated 
with ethanol and NaCl, as above, and stored in 1 mM potas-
sium acetate buffer (pH 5.5) containing 0.1 mM MgCl2. The 
enzymatic labeling of truncated tRNA
Ile at its 3'-end, fol-
lowed by the chromatographic step, yielded 13.7 mg of total 
tRNA containing 3% of [
14C]tRNA
Ile species, which corre-
sponded to a yield of 83% of the initial amount of unfrac-
tionated E. coli tRNA (16.5 mg). The specific radioactivity 
of [
14C]tRNA
Ile molecules in the mixture, as measured by 
trichloroacetic acid precipitation, was 9,000 counts per min-
ute per nanomole of radiolabeled tRNA. 
Inactivation and Labeling of IleRS by Periodate-Oxidized 
tRNA
Ile 
 tRNA
Ile (0.8 nmol of isoleucine acceptance/A260 unit of 
tRNA) or [
14C]tRNA
Ile (specific radioactivity 9,000 
counts.min
-1.nmole
-1) were oxidized with NaIO4  as in [1]. 
Kinetics of inactivation of IleRS (1 μM) by periodate-
oxidized tRNA
Ile (tRNA
Ileox 4 μM) were followed at 37°C in 
20 mM imidazole hydrochloride (pH 8.0) containing 25% 
glycerol, 10 mM MgCl2, and 2 mM NaBH3CN. At various 
times, 10 μL aliquots of the incubation mixture were diluted 
in imidazole hydrochloride buffer (pH 7.6) containing 10 
mM 2-mercaptoethanol, 0.1 mM EDTA and 200 μg/mL bo-
vine serum albumin, and assayed for isoleucine-dependent 
isotopic ATP-PPi exchange and tRNA
Ile aminoacylation ac-
tivities [24, 25]. 
  For stoichiometry measurements, IleRS (3 μM) was in-
cubated with 396 μM of the unfractionated tRNA sample 
containing 12 μM of periodate-oxidized [
14C]tRNA
Ile 
([
14C]tRNA
Ileox) (specific radioactivity 9,000 counts.min
-
1.nmole
-1), in the same conditions as above. At various times, 
portions of the incubation mixture were withdrawn and as-
sayed for enzymatic activity. In parallel, aliquots were sub-
mitted to ribonuclease A digestion (10 μg/mL) for 2 min. 
Incorporation within the enzyme of the [
14C]radioactivity 
was followed by precipitation with 5% trichloroacetic acid, 
as already described [1]. 
Preparation of IleRS-[
14C]tRNA
Ileox Covalent Complex 
 IleRS  (3  μM in 5 mL) was incubated with 12 μM perio-
date-oxidized [
14C]tRNA
Ile (specific radioactivity 9,000 
counts.min
-1.nmole
-1) in the same conditions as above, and 
the [
14C]adenosine incorporation in the enzyme was followed 
by submitting aliquots of the incubation mixture to ribonu-
clease A digestion and trichloroacetic acid precipitation [1]. 
At 150 min, when 97% of the initial IleRS activity was lost, 
while 1 mol of [
14C]tRNA
Ileox was incorporated per mol of 
enzyme, the reaction was quenched by the addition of 25 
mM NaBH4. In order to separate the IleRS-[
14C]tRNA
Ileox 
covalent complex from the excess of tRNA, the reaction 
mixture was loaded onto a Sephadex G-100 column equili-
brated with 0.1M ammonium acetate (pH 8.0). Elution was 
monitored by radioactivity measurement. The IleRS-
[
14C]tRNA
Ileox complex was vacuum-dried. 
Preparation and Purification of [
14C]tRNA
Ileox-Labeled 
Peptides of IleRS 
  The labeled IleRS was digested with -chymotrypsin for 
4h at 37°C, at a protease to synthetase ratio of approximately 
1/50 (w/w). The chymotryptic digestion was stopped by add-
ing phenylmethanesulfonyl fluoride (PMSF) at a final con-
centration of 0.5 mM. Peptide purification from the chymo-
tryptic digest of the IleRS-[
14C]tRNA
Ileox covalent complex 
was performed by a two-step chromatography on Sephadex 
G-50 as already described [3-5], followed by further purifi-
cation by reverse-phase high-performance liquid chromatog-
raphy (RPLC) on a Merck Superspher RP18 column (250 x 4 
mm, 4 μm particles, 10 nm pore size). Peptides were eluted 
with a linear gradient (from 0 to 80% B) with the following 
eluents: A, 0.1% trifluoroacetic acid in water; B, 0.1% 
trifluoroacetic acid and 80% acetonitrile in water. 
Inactivation and Labeling of IleRS by Pyridoxal 5'-
diphospho-5'-adenosine
 
  Pyridoxal 5'-diphospho-5'-adenosine (ADP-PL) was syn-
thesized and purified as already described [26]. Its molar 
absorption coefficients in 0.1 N NaOH were 5060 M
-1
.cm
-1
 
at 394 nm and 5550 M
-1
.cm
-1
 at 393 nm, respectively. Inac-
tivation of IleRS (6 μM) by ADP-PL (1 mM) was carried out 
at 37°C, in 50 μL of 50 mM Hepes/Na (pH 7.8). At various 
times, 5-μL portions of the incubation mixtures were with-
drawn and quenched by the addition of 10 μL of freshly pre-
pared 0.1 M NaBH4 in 50 mM Hepes/Na (pH 7.8), followed 
by dilution with 0.5-1 mL Tris/HCl pH 7.6, containing 10 
mM 2-mercaptoethanol, 0.1 mM EDTA, and 200 μg/mL 
bovine serum albumin. The diluted portions were assayed for 
the isoleucine-dependent isotopic ATP-PPi exchange and 
tRNA
Ile aminoacylation activities [24, 25]. 
  Incorporation of ADP-PL into IleRS was monitored as 
already described [7]. IleRS (6 μM) was incubated at 37°C 
in 50 μL of 50 mM Hepes/Na (pH 7.8) containing 0.2-3 mM 
ADP-PL. After 90 min, each incubation mixture was added 
to 10 μL of freshly prepared 0.1 M NaBH4  in 50 mM 
Hepes/Na (pH 7.8). 5 μL of each NaBH4-treated sample was 
diluted and assayed for the isoleucine-dependent isotopic 
ATP-PPi exchange and tRNA
Ile aminoacylation activities 
[24, 25]. In parallel, a 50 μL aliquot was analysed by size 
exclusion chromatography on a TSK 4000 PW column (300 
mm x 7.5 mm) with 0.2 M ammonium acetate (pH 7.5) as 
eluent, to separate the covalently bound and the unbound 
NaBH4-reduced ADP-PL. Elution was monitored by absor-
bance measurement at 325 nm; a molar absorption coeffi-
cient of 8800 M
-1.cm
-1 (pH 7.5) at 325 nm was used to quan-
tify the amount of pyridoxyl group covalently bound to the 
enzyme [26-28].  
Inactivation of IleRS by Bromomethyl Ketone Derivatives 
of Amino Acids 
  Bromomethyl ketone derivatives of amino acids were 
synthesized as already described [12]. Isoleucyl-tRNA syn-Binding Site for tRNA
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thetase (IleRS), stored in 20 mM Tris-HCl buffer (pH 7.8) 
containing 50% glycerol and 10 mM 2-mercaptoethanol, was 
extensively dialyzed against the appropriate buffer prior to 
incubation with a given reagent. Inactivation of IleRS (2 
μM) was carried out in the presence of either of the bro-
momethyl ketone derivatives (Fig. 1) of various amino acids 
(IBMK, VBMK, NleBMK or FBMK) at a final concentra-
tion of 2 mM, at 37°C in 50 μl of 50 mM Hepes/Na, pH 7.8. 
  At various times, 5 μL aliquots of the incubation mix-
tures were withdrawn and quenched by a 100 fold dilution 
with 20 mM Tris-HCl buffer (pH 7.8) containing 200 μg/mL 
of bovine serum albumin and 50 mM 2-mercaptoethanol. 
The diluted portions were assayed for the isoleucine-
dependent isotopic ATP-PPi exchange and tRNA
Ile aminoa-
cylation activities [24, 25]. 
Inactivation of IleRS by Diethyl Pyrocarbonate 
  Inactivation of IleRS (2 μM) with 0.5 mM diethyl pyro-
carbonate (DEPC) was performed in 50 mM potassium 
phosphate buffer (pH 6.5) by adding the reagent dissolved in 
absolute ethanol to the enzyme solution. Final ethanol con-
centration was less than 2%, which had no effect on enzyme 
activity. The controls contained equal volumes of ethanol. 
The concentration of DEPC solutions was deduced by reac-
tion with free imidazole of known concentration, using a 
molar absorption coefficient at 240 nm and pH 6.5 of 3200 
M
-1.cm
-1. At various times, 5 μL aliquots of the incubation 
mixture were withdrawn and diluted at least 100 fold with 20 
mM Tris-HCl buffer (pH 7.8) containing 200 μg/mL of bo-
vine serum albumin and 10 mM 2-mercaptoethanol. 
Proteolytic Digestion and Peptide Separation 
  After 1-2 hours of incubation of IleRS with the bro-
momethyl ketone derivatives of amino acids, or with DEPC, 
when the assayed diluted portions had reached the maximum 
inactivation level, the incubation mixtures were extensively 
dialyzed against 0.1 M ammonium acetate (pH 8.0). What-
ever the used reagent, labeled IleRS was digested overnight 
at 37°C with TosPheCH2Cl-treated trypsin at a protease to 
substrate ratio of 1/20 (w/w).  
  ADP-PL-labeled peptides were purified at room tempera-
ture on a Vydac C18 reverse-phase column (150 mm x 2.1 
mm; 5 μm particles), at a flow rate of 0.25 mL/min (Applied 
Biosystems model 140A HPLC gradient system, and model 
1000S diode array detector). Peptides were eluted with a 
linear gradient composed of the following solutions: solution 
A, 0.1% TFA in water; solution B, 0.1% TFA and 80% ace-
tonitrile in water and 0.25 mL fractions were collected. 
  Peptides labeled with IBMK, VBMK, NleBMK, FBMK 
were separated on a BioCad Sprint (Perkin Elmer Biosys-
tems) HPLC system equipped with a C18 reverse-phase col-
umn (4.6 x 250 mm, 5 μm particles from Interchim), at a 
flow rate of 1 mL/min. Tryptic digests were injected into the 
column equilibrated with 0.1% TFA in water (solvent A). 
Linear gradients of acetonitrile were developed from 10% to 
100% B during 60 min (solvent B: 10% solvent A in acetoni-
trile) and 1 mL fractions were collected. 
  In the case of DEPC-labeled peptides, in order to prevent 
the removal of ethoxyformyl groups during the chroma-
tographic separation, elution was achieved with linear gradi-
ents of acetonitrile in 1mM potassium phosphate buffer (pH 
7.0). As a control, the ethoxyformyl groups of DEPC-labeled 
peptides was removed by hydroxylamine as follows: vac-
uum-dried DEPC-labeled peptides were dissolved in 0.1 M 
Tris-HCl (pH 7.0) containing 0.1 M hydroxylamine adjusted 
to pH 7.0. Under this condition, optimal removal of the 
ethoxyformyl group was obtained after 30-60 min of incuba-
tion at 28°C.  
Mass Spectrometry 
  Peptide samples were prepared by mixing 1 μL of matrix 
solution [100 mM -cyano-4-hydroxy-cinnamic acid (HP 
G2037A or Sigma) in 50 % acetonitrile, 0.1% trifluoroacetic 
acid] with 1 μL peptide solution (1-10 pmol). This mixture 
was then loaded on the probe tip and dried.  
  MALDI mass spectra of labelled peptides were obtained 
in the linear mode with time of flight mass spectrometers 
(Hewlett Packard G2025 or MicromassVG Tofspec). From 
100 to 200 shots were accumulated for each spectrum acqui-
sition in the positive-ion mode. Calibration with external 
standards was obtained with a mixture of peptide standards 
(HP G2052A) in the range 1000-7000 Da. High resolution 
MALDI-MS of IleRS digests was performed with a Bruker 
Reflex III mass spectrometer operated in the reflectron mode 
with the same matrix as above. For sequence confirmation, 
post source decay (PSD) spectra of fragment ions from a 
selected precursor were acquired in 11-13 voltage steps, 
starting at 30 kV reflector voltage, with an ion gate operated 
at a resolution of approximately 150.  
N-Terminal Sequencing 
  A Model 470A sequencer (Applied Biosystems) was 
used for automated Edman degradation of purified 
[
14C]tRNAox-labeled peptides. Samples (30 μL aliquots, 
100-200 pmol) were loaded on glass fiber filters that had 
been previously treated with 2.5 mg of Biobrene (Applied 
Biosystems) and submitted to three precycles. The 03RPTH 
program, modified for our on-line PTH identification setup, 
was used for sequencing. Automated on-line PTH analysis 
was performed as described in [29]. 
RESULTS 
Correction of E. coli IleRS Sequence 
  Two IleRS sequences were retrieved from databases. The 
first sequence was published as an aminoacid sequence only 
[17], whereas the second sequence [18], is a nucleotidic se-
quence. As revealed by protein sequence alignment, there are 
15 stretches where conflicts occur between these sequences. 
A previous MALDI-MS peptide mapping experiment dem-
onstrated that none of these primary structures is correct. 
These findings were reinforced by codon usage analysis and 
multiple alignment with IleRS sequences from other species 
[30].  
  A correct sequence was then definitely established by 
means of peptide mapping using a set of four endoproteases 
(trypsin, LysC, AspN and GluC) and MALDI-MS analysis 
of the released peptides. When necessary, sequence confir-
mation was obtained by means of PSD fragment analysis 
[20]. Thus, the first sequence [17] had 6 errors, while the 
second [18] had 9 wrong sequence stretches. The correct 
sequence (937 residues, average molecular mass 104362 Da) 30    The Open Biochemistry Journal, 2009, Volume 3  Baouz et al. 
is given in Fig. 2, and primary structure numbering given in 
this work refers to this sequence only.  
Inactivation and Labeling of IleRS by Periodate-Oxidized 
[
14C]tRNA
Ile 
  The isoleucine-specific component of unfractionated E. 
coli tRNA representing 3% of the total tRNA, was charged 
with L-isoleucine, followed by periodate oxidation of the 
non-specific tRNAs which were not aminacylated with iso-
leucine, to yield tRNAox. The tRNAox molecules were fur-
ther reduced to tRNAox-red with sodium borohydride, while 
the tRNA molecules specific for L-isoleucine, and which 
were charged with this amino acid in the presence of IleRS, 
were deacylated and converted to [
14C]tRNA
Ile by combining 
periodate, lysine, alkaline phosphatase and nucleotidyl-
transferase treatments, as already described [23]. Altogether, 
these treatments yielded [
14C]tRNA
Ileox molecules with a 
specific radioactivity of 9,000 counts.min
-1.nmole
-1, in a 
mixture with various tRNAox-red species. 
  When IleRS (1 μM) was incubated with 4 μM of perio-
date-oxidized tRNA
Ile (tRNA
Ileox), the isoleucine-dependent 
isotopic [
32P]PPi-ATP exchange and tRNA
Ile aminoacylation 
activities of the synthetase were lost by more than 95% (Fig. 
3). The kinetics of inactivation fitted single exponential 
curves, with an estimated rate constant of inactivation of 
0.037 min
-1 and 0.025 min
-1 in the tRNA
Ile aminoacylation 
and isoleucine-dependent isotopic [
32P]PPi-ATP exchange 
activities, respectively (Fig. 3). Intact E. coli tRNA
Ile at a 
final concentration of 10 μM fully protected the enzyme (1 
μM) against inactivation and labeling by tRNA
Ileox (4 μM). 
Combination of L-isoleucine (8 mM) and ATP-Mg
2+ (8 mM) 
also afforded full protection (Fig. 3). 
  Similarly, when IleRS (3 μM) was incubated in the pres-
ence of 396 μM of unfractionated tRNAox-red sample con-
taining 12 μM of periodate-oxidized [
14C]tRNA
Ile, the iso-
leucine-dependent isotopic [
32P]PPi-ATP exchange and 
tRNA
Ile aminoacylation activities of the synthetase were lost, 
in parallel with the incorporation of (1.10 + 0.05) mol of 
[
14C]tRNA
Ileox per mol of E. coli IleRS (Fig. 4), in agree-
ment with the 1:1 enzyme:tRNA active stoichiometry. 
Treatment with NaBH4 (5 mM) of the tRNA sample contain-
ing the [
14C]tRNA
Ileox species, prior to incubation with Il-
eRS, prevented inactivation and labeling of the synthetase, 
suggesting that only the periodate-oxidized isoleucine-
specific component of the total tRNA specifically reacts with 
this synthetase. 
  Altogether, these results strongly suggest that the oxi-
dized CCA-arm of enzyme-bound tRNA
Ile actually reacts 
with lysyl residues at or near the catalytic center of E. coli 
IleRS. 
Inactivation and Labeling of IleRS by Pyridoxal 5'-
diphospho-5'-adenosine 
  Upon incubation with 1 mM ADP-PL, followed by re-
duction with sodium borohydride, the isoleucine-dependent 
isotopic [
32P]PPi-ATP exchange and tRNA
Ile aminoacylation 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (2). Corrected E. coli isoleucyl-tRNA synthetase primary structure (IRS) is presented together with sequence I1 taken from Webster et 
al. [17] and sequence I2 from Yura et al. [18]. The 15 error zones, 6 for I1 and 9 for I2, are indicated in bold. 
SDYKSTLNLP ETGFPMRGDL AKREPGMLAR WTDDDLYGII RAAKKGKKTF 050 
ILHDGPPYAN GSIHIGHSVN KILKDIIVKS KGLSGYDSPY VPGWDCHGLP 100  
IELKVEQEYG KPGEKFTAAE FRAKCREYAA TQVDGQRKDF IRLGVLGDWS 150 
HPYLTMDFKT EANIIRALGK IIGNGHLHKG AKPVHWCVDC RSALAEAEVE 200 
YYDKTSPSID VAFQAVDQDA LKAKFAVSNV NGPISLVIWT TTPWTLPANR 250 
AISIAPDFDY ALVQIDGQAV ILAKDLVESV MQRIGVTDYT ILGTVKGADV 300 
ELLRFTHPFM GFDVPAILGD HVTLDAGTGA VHTAPGHGPD DYVIGQKYGL 350 
ETANPVGPDG TYLPGTYPTL DGVNVFKAND IVVALLQEKG ALLHVEKMQH 400 
SYPCCWRHKT PIIFRATPQW FVSMDQKGLR AQSLKEIKGV QWIPDWGQAR 450 
IESMVANRPD WCISRQRTWG VPMSLFVHKD TEELHPRTLE LMEEVAKRVE 500 
VDGIQAWWDL DAKEILGDEA DQYVKVPDTL DVWFDSGSTH SSVVDVRPEF 550 
AGHAADMYLE GSDQHRGWFM SSLMISTAMK GKAPYRQVLT HGFTVDGQGR 600 
KMSKSIGNTV SPQDVMNKLG ADILRLWVAS TDYTGEMAVS DEILKRAADS 650 
YRRIRNTARF LLANLNGFDP AKDMVKPEEM VVLDRWAVGC AKAAQEDILK 700 
AYEAYDFHEV VQRLMRFCSV EMVSFYLDII KDRQYTPKRT VWARRSCQTA 750 
LYHIAEALVR WMAPILSFTA DEVWGYLPGE REKYVFTGEW YEGLFGLADS 800 
EAMNDAFWDE LLKVRGEVNK VIEQARADKK VGGSLEAAVT LYAEPELSAK 850 
LTALGDELRF VLLTSGATVA DYNDAPADAQ QSEVLKGLKV ALSKAEGEKC 900 
PRCWHYTQDV GKVAEHAEIC GRCVSNVAGD GEKRKFA 937 Binding Site for tRNA
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activities of IleRS (6 μM in 50 μL) were lost by more than 
97% within 30 min (Fig. 5), in parallel with the incorpora-
tion of (0.98 + 0.03) mole of ADP-PL/mole of IleRS (Fig. 
6).  
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (5). Time course of inactivation of IleRS by ADP-PL. 
IleRS (6 μM) was incubated with 1 mM ADP-PL, as described 
under Methods. Kinetics of enzyme activity loss were superimpos-
able for isoleucine-dependent isotopic [
32P]PPi-ATP exchange and 
tRNA
Ile aminoacylation activities ( ,  ,  ). The control experi-
ments () were without ADP-PL or with 1 mM ATP instead of 
ADP-PL. For the protection experiments (), the enzyme was pre-
incubated with 8 mM L-isoleucine and 8 mM ATP-Mg
2+ prior to 
ADP-PL addition. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (6). Stoichiometry of labeling of IleRS by ADP-PL. 
IleRS (6 μM) was incubated with 0.2-3 mM ADP-PL, as described 
under Methods. The residual enzyme activity is plotted against the 
molar fraction of ADP-PL incorporated per mole of enzyme (n), as 
deduced from the absorbance at 325 nm of NaBH4-reduced ADP-
PL covalently bound to IleRS and separated from the unbound rea-
gent by chromatography through a TSK 4000 PW column. 
 
  These results agree with the known presence of one bind-
ing site for MgATP on IleRS. The kinetics of inactivation 
fitted a single exponential curve, with an estimated rate con-
stant of inactivation of the tRNA
Ile aminoacylation and iso-
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (3). Time course of inactivation of IleRS by tRNA
Ileox. 
IleRS (1 μM) was incubated with 4 μM tRNA
Ileox, as described 
under Methods. The residual isoleucine-dependent isotopic 
[
32P]PPi-ATP exchange ( ,  , ) and tRNA
Ile aminoacylation 
( , , ) activities were measured as a function of time. The con-
trol experiments ( , ) were without tRNA
Ileox or with 4 μM 
intact tRNA
Ile instead of tRNA
Ileox. For the protection experiments 
( , ), 20 μM of intact tRNA
Ile was present with the enzyme prior 
to tRNA
Ileox addition. In another protection experiment, IleRS (1 
μM) was pre-incubated with a combination of 8 mM MgATP and 8 
mM L-isoleucine, prior to tRNA
Ileox addition. In the latter case, 
kinetics of enzyme activity loss for isoleucine-dependent isotopic 
[
32P]PPi-ATP exchange and tRNA
Ile aminoacylation activities were 
superimposable on those of the controls ( , ).  
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (4). Stoichiometry of labeling of IleRS by 
[
14C]tRNA
Ileox.IleRS (3 μM) was incubated with 396 μM of 
unfractionated tRNA sample containing 12 μM of [
14C]tRNA
Ileox 
(specific radioactivity 9,000 counts.min
-1.nmole
-1). The number of 
[
14C]tRNA
Ileox molecules (n) incorporated per mol of enzyme is 
represented as a function of the residual isoleucine-dependent iso-
topic [
32P]PPi-ATP exchange () and tRNA
Ile aminoacylation () 
activities. The control experiments in the presence of intact 
[
14C]tRNA
Ile showed no incorporation of radioactivity. 32    The Open Biochemistry Journal, 2009, Volume 3  Baouz et al. 
leucine-dependent isotopic [
32P]PPi-ATP exchange activities 
of 0.4 min
-1 (Fig. 5). Combination of L-isoleucine (8 mM) 
and ATP-Mg
2+ (8 mM) protected the enzyme against inacti-
vation by ADP-PL (Fig. 5).  
  As shown in Fig. (7), the relationship between the frac-
tion of inactivated IleRS and the concentrations of free ADP-
PL in the incubation mixtures is hyperbolic, indicating that a 
reversible enzyme-reagent complex is formed prior to the 
labeling. From the saturation curve obtained, the dissociation 
constant for the non-covalent enzyme-reagent intermediate 
was estimated to be 0.17 mM, which is similar to the Kd 
value (0.176 mM) of ATP binding to IleRS [31]. Altogether, 
these results suggest that, when bound to IleRS, ADP-PL is 
well fitted to the ATP-binding site. 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (7). Saturation of IleRS by ADP-PL. 
The incubation mixtures were the same as in Figure 5. The fraction 
of inactivated IleRS, as deduced from kinetics data from Figure 5, 
is represented as a function of free ADP-PL concentration. From 
this saturation curve, the half-effect concentration of ADP-PL in the 
inactivation of IleRS was estimated to be 0.17 mM. 
 
Inactivation of IleRS with Bromomethyl Ketone Derivatives 
of Various Amino Acids 
  More than 97% of the isoleucine-dependent isotopic 
[
32P]PPi-ATP exchange activity of E.coli IleRS (2 μM in 50 
μL) was lost within 30 min, upon incubation with 2 mM 
IBMK, with an estimated rate constant of inactivation of 
0.34 min
-1 (Fig. 8). The effects of substrates on the inactiva-
tion of IleRS by IBMK were examined (Fig. 8). The pres-
ence of 8 mM MgATP provided substantial protection, while 
the presence of 8 mM L-isoleucine alone or in combination 
with 8 mM MgATP afforded full protection. Protection of 
IleRS by L-isoleucine against inactivation by IBMK was not 
the result of the reaction of this reagent with the -amino 
group of the amino acid, since 8 mM L-valine afforded no 
protection (Fig. 8).  
  The relationship between the fraction of IBMK-
inactivated IleRS and the concentrations of IBMK in the 
incubation mixtures is hyperbolic (Fig. 9), indicating that a 
reversible IleRS/IBMK complex is formed prior to the label-
ing. From the saturation curve obtained, the half-effect con-
centration of IBMK in the inactivation of IleRS was esti-
mated to be 0.1 mM. Even though the latter value is much 
larger than the Kd value (6.8 μM) of isoleucine binding to 
IleRS [31], this saturation behavior might reflect that, when 
bound to IleRS, IBMK is well fitted to the isoleucine-
binding site. Altogether, these results would indicate that the 
substrate analog IBMK reacts with nucleophilic amino acid 
residues at or near the isoleucine binding site of IleRS. 
  Similarly, incubation of IleRS with either of the used 
bromomethyl ketone derivatives of non-cognate amino acids 
resulted in a time-dependent inactivation of the isoleucine-
dependent isotopic [
32P]PPi-ATP exchange activity. How-
ever, under the same conditions, the estimated rate constants 
of inactivation of IleRS (2 μM) by the latter reagents at a 
final concentration of 2 mM were lower than that of IBMK 
(0.15, 0.15, and 0.072 min
-1 for VBMK, NleBMK and 
FBMK, respectively), versus 0.34 min
-1 for (IBMK) (Fig. 8), 
suggesting that these reagents are not equally accessible to 
the target residues in the active site of the enzyme. 
  As a control, the effect on IleRS activity of diethylpyro-
carbonate (DEPC), a reagent having a structure unrelated to 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (8). Inactivation of IleRS by bromomethyl ketones derived 
from amino acids. 
The enzyme (2 μM) was incubated at 37°C in 50 mM Hepes/Na 
(pH 7.8), with IBMK (  ), NleBMK (  ), VBMK (  ) or FBMK 
( ), at a final concentration of 2 mM. Control experiments (  ) 
were carried out in the absence of reagent. Aliquots of the incuba-
tion mixtures were withdrawn, quenched by dilution with a buffer 
that contained 50 mM 2-mercaptoethanol, and assayed for the iso-
leucine-dependent isotopic [
32P]PPi-ATP exchange activity, as 
described under Methods. For the protection experiments, the en-
zyme was pre-incubated with 8 mM MgATP (  ) or 8 mM L-
isoleucine (  ), prior to IBMK addition. The combination of 8 mM 
MgATP and 8 mM L-isoleucine was as efficient as 8 mM L-
isoleucine alone in the protection of IleRS against inactivation by 
IBMK. Pre-incubation of IleRS with 8 mM L-valine prior to IBMK 
addition did not affect the kinetics of inactivation of the synthetase 
by this cognate amino acid analog (  ). 
Data are plotted as the percent of activity remaining versus incuba-
tion time. Binding Site for tRNA
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amino acids, which reacts preferentially with histidine side 
chains, was also examined. Incubation of IleRS (2 μM in 50 
μL) with 0.5 mM DEPC resulted in a complete inactivation 
of the synthetase (results not shown). L-isoleucine (2 mM) or 
L-isoleucine (2 mM) associated to MgATP (2 mM) afforded 
full protection against inactivation of IleRS by DEPC (re-
sults not shown). 
  Altogether, these results suggest that nucleophilic amino 
acid residues critical for activity such as cysteines or histidi-
nes, located within the enzyme active site or in the vicinity 
thereof are the targets of the various used reagents. 
Preparation of Labeled Peptides of IleRS 
  A covalent IleRS-[
14C]tRNA
Ileox complex (96% inacti-
vated) was digested with ribonuclease-free chymotrypsin. In 
order to counterselect the tRNA-labeled chymotryptic pep-
tides from the unlabeled ones, the digest was fractionated in 
two steps by size exclusion chromatography on Sephadex G-
50, as already described [3-5]. In the first step, the 
[
14C]tRNA-labeled peptides in which the tRNA moiety had 
remained intact eluted as a single peak in the void volume of 
the first Sephadex G-50 column, as expected. This step sepa-
rated the tRNA-bound peptides from the bulk of smaller un-
labeled ones. In the second step, the radioactive material 
recovered from the first step was treated with ribonuclease A 
and loaded on a second Sephadex G-50 column. This second 
chromatography separated the [
14C]adenosine-labeled pep-
tides from the large unlabeled ones, which might have coe-
luted in the void volume of the first column [3-5]. 
[
14C]Adenosine-labeled peptides eluted as a single peak 
which was recovered for further purification by reverse-
phase high-performance liquid chromatography (RPLC) on a 
Superspher RP18 column. The majority of the labeled mate-
rial (85% of the applied radioactivity) was recovered as a 
single peak close to the void volume of the RPLC column 
(results not shown). 
  Other labeled peptides were obtained from IleRS samples 
that have been inactivated by 96%, 98%, 98%, 97%, 90% 
and 97%, in the presence of ADP-PL, IBMK, VBMK, 
NleBMK, FBMK and DEPC, respectively. Tryptic digests of 
labeled IleRS were separated by RPLC. As a control, an in-
tact IleRS sample was submitted to trypsin digestion and 
RPLC separation in the same conditions as the labeled syn-
thetase.  
  Peptides (215 nm absorbing fractions) obtained in a la-
beling experiment were analysed by MALDI-MS. Similarly, 
the corresponding 215 nm absorbing fractions of the entire 
RPLC chromatographic profile of the control were also ana-
lysed by MALDI-MS. Distinction between labeled and unla-
beled peptides, as well as assignment of the ADP-PL-, 
IBMK-, VBMK-, NleBMK-, FBMK- or DEPC-labeled pep-
tides were achieved by comparing the molecular masses of 
fractions containing 215 nm absorbing material obtained in a 
labeling experiment to those of the corresponding fractions 
in the control. In the cases of ADP-PL- or FBMK- labeled 
peptides, peptide elution was also monitored at 260 nm (ade-
nine or Phe detection). 
Analysis of Labeled Peptides by MALDI-MS or Automated 
Edman Degradation 
  Labeled peptides were identified by means of MALDI-
MS analysis, using the mass increase values corresponding 
to the binding of ADP-PL, IBMK, NleBMK, FBMK, VBMK 
and DEPC (561.1, 127.1, 127.1, 161.1, 113.1 and 72.1 
Daltons, respectively; cf Fig. 1). Mass values of IleRS la-
beled peptides are given in Table 1. Accordingly, ADP-PL-
labeled peptides corresponded respectively to stretches 
601KMSK
604 and 
602MSKSIGNTVSPQDVMNK
618 in the 
primary structure of E. coli IleRS (Fig. 2). Thus, the two 
lysyl residues of the consensus sequence 
601KMSKS
605 were 
labeled with this reactive ATP analog. 
 
  In total, peptides labeled by bromomethyl ketone deriva-
tives of amino acids correspond respectively to stretches 
305FTHPFMG....DYVIGQK
347, 
390GALLHVEK
397, 
451IESM 
VANRPDWCISR
465, 
468TWGVPMSLFVHK
479 and 
717FCS 
VEMVSFYLDIIK
731 in the primary structure of E. coli Il-
eRS. Among these, VBMK-labeled fragment 305-347 con-
tains four histidyl residues of which only one was expected 
to be attached to the label (Table 1). In order to identify the 
labeled histidyl residue of this fragment, this VBMK-labeled 
peptide was further digested with chymotrypsin, and ana-
lysed by MALDI-MS. Only one modified peptide was found 
at m/z 1851.7 Da, corresponding to the mass of fragment 
325-342 (calculated mass 1738.7) modified with one valyl 
moiety (mass adduct 113.1). As a consequence, the labeled 
histidyl residue of the parent VBMK-labeled fragment 305-
347 is His-332 or His-337.  
  Thus, the amino acid residues of E. coli IleRS labeled by 
the amino acid-derived bromomethyl ketones were His-332 
(or His-337), His-394, Cys-462, His-478 and Cys-718.  
  DEPC-labeled peptides corresponded respectively to po-
sitions 
583APYRQVLTHGFTVDGQGRKMSK
604 and 
890VALSKAEGEKCPRCWHYTQDVGK
912 in the primary 
structure of E. coli IleRS (Table 1), and the labeled residues 
were thus His-591 and His-905, respectively. Identification 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (9). Saturation of IleRS by IBMK. 
The incubation mixtures were the same as in Figure 8. The fraction 
of IBMK-inactivated IleRS, as deduced from kinetics data from 
Figure 8, is represented as a function of free IBMK concentration. 
From this saturation curve, the half-effect concentration of IBMK 
in the inactivation of IleRS was estimated to be 0.1 mM. 34    The Open Biochemistry Journal, 2009, Volume 3  Baouz et al. 
of the labeled histidine residues was ascertained by removal 
of the ethoxyformyl groups of DEPC-labeled peptides with 
the help of 0.1 M hydroxylamine in 0.1 M Tris-HCl (pH 
7.0), as described under Methods, followed by MALDI-MS 
analysis of the recovered unlabeled peptides. 
  When the [
14C]tRNA
Ileox-labeled peptides of IleRS, 
eluted as a single peak close to the void volume of the C18 
RPLC column, were analyzed by MALDI mass spectrome-
try, no signal could be found. Therefore, the peptidic mate-
rial of this peak was submitted to N-terminal sequencing by 
automated Edman degradation. A unique [
14C]tRNAox-
labeled peptide was found in this peak, the sequence of 
which was 
603SKSIGN
608. Thus, the tRNA
Ileox-labeled resi-
due of IleRS was Lys-604. 
DISCUSSION 
Primary Structure Revision of E. coli IleRS 
  Most of the errors in the two published IleRS primary 
structures are related to shifts in the nucleotide reading 
frame. The two wrong sequences were left as such for a long 
time, probably because the first sequence was published as a 
protein sequence only [17] and the second sequence [18] was 
not cross-checked with the first one. The combination of 
peptide mass mapping by MALDI-MS and PSD fragmenta-
tion of peptide ions was a fast way to determine the correct 
sequence. The involvement of a set of four different prote-
ases was required for a total sequence coverage of this 104 
kDa enzyme. Cleavage specificities of these proteases were 
helpful for solving single residue conflicts such as C vs R at 
location 586, Q vs E at location 636 and N vs K at location 
829. 
Analogy with the 3-D Structures of IleRS from Thermus 
Thermophilus and Staphylococcus aureus 
  The crystal structures at 2.5 Å resolution of IleRS from 
T. thermophilus in complexes with L-isoleucine and L-valine 
were previously reported [15], as well as that at 2.2 Å resolu-
tion of S. aureus IleRS complexed with tRNA
Ile and mupiro-
cin [16]. 
  Alignment of the amino acid sequence of several IleRS 
from different origins reveals an average of 35 % identities 
or conservative replacements (results not shown). Since it is 
generally believed that proteins sharing more than 30% pri-
mary structure similarity are somewhat similarly folded, it 
can be reasonably expected that the isoleucyl-tRNA syn-
Table 1.  Matrix Assisted Laser Desorption-Ionization Mass Spectrometry (MALDI-MS) of ADP-PL-, IBMK-, VBMK-, NleBMK-, 
FBMK- and DEPC-Labeled Peptides of IleRS 
Labeled Peptide Sequence  Measured Mass  Calculated Mass  Mass Diff.  Labeled Residue 
ADP-PL-labeled peptides      
601KMSK604   1055.1  493.6 561.5 K601 
602MSKSIGNTVSPQDVMNK618 2398.7  1837.1  561.6  K604 
IBMK-labeled peptides      
451IESMVANRPDWCISR465 1904.9  1777.1  127.8  C462 
717FCSVEMVSFYLDIIK731  1921.5  1794.2  127.3  C718 
VBMK-labeled peptides      
305FTHPFMG......DYVIGQK34 4574.5  4461.0  113.5  ? 
325DAGTGA…PGHGPDDY342 1851.7  1738.7  113.0  H332/337 
390GALLHVEK397   980.5    867.0 113.5 H394 
451IESMVANRPDWCISR465 1890.6  1777.1  113.5    C462 
468TWGVPMSLFVHK479 1515.5  1402.7  112.8  H478 
717FCSVEMVSFYLDIIK731 1907.7  1794.2  113.5  C718 
NleBMK-labeled peptides      
390GALLHVEK397  993.6 867.0 126.6 H394 
451IESMVANRPDWCISR465 1904.7  1777.1  127.6  C462 
468TWGVPMSLFVHK479 1529.1  1402.7  126.4  H478 
717FCSVEMVSFYLDIIK731 1921.8  1794.2  127.6  C718 
FBMK-labeled peptides      
390GALLHVEK397  1027.7   867.0   160.7  H394 
468TWGVPMSLFVHK479 1563.5  1402.7  160.8  H478 
717FCSVEMVSFYLDIIK731 1955.1  1794.2  160.9  C718 
DEPC-labeled peptides      
583APYRQVLTHG…KMSK604  2550.0 2477.8 72.2  H591 
890VALS…CWHYTQDVGK912  2677.3 2605.0 72.3  H905 
Masses, corresponding to [M + H]
+ ions, are calculated (unlabeled peptides), or observed. Mass differences correspond to the covalent addition of one reagent (theoretical values are 
561.1 for ADP-PL, 127.1 for L-isoleucine, 113.1 for L-valine, 127.1 for L-norleucine, 161.1 for L-phenylalanine and 72.0 Da for DEPC, cf Fig. 1). Binding Site for tRNA
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thetases from E. coli, T. thermophilus and S. aureus present 
similar overall three-dimensional structures. Therefore, our 
labeling data can be discussed on the basis of the 3-D struc-
tures of IleRS from T. thermophilus and S. aureus [15, 16].  
  The crystal structure of S. aureus IleRS is composed of 
three regions of differing functions: a region that binds the 
tRNA anticodon loop, a catalytic core that activates and 
transfers the amino acid and an editing domain that removes 
any incorrectly incorporated amino acid [16].  The amino 
acid residues labeled by tRNA
Ileox or ADP-PL, as well as by 
IBMK, NleBMK, FBMK or VBMK, or the histidine-specific 
reagent DEPC, are mainly distributed between four regions 
in the primary structure of IleRS: these are fragments [325-
394], [451-479], [591-604] and [718-905] (Table 1). In the 
3-D structures of IleRS from T. thermophilus and S. aureus, 
fragment [325-394] is part of the editing domain, while 
fragments [451-479] and [591-604] representing the iso-
leucine binding domain and the dinucleotide (or Rossmann) 
fold domain, respectively, are located in the catalytic core. 
  All the thiol-specific reagents used (including the sub-
strate analog IBMK) were found covalently attached to Cys-
718 (Table 1), in the C-terminal region of E. coli IleRS. 
These results would suggest that Cys-718 was unspecifically 
labeled, due to its special reactivity toward alkylation by the 
bromoketone moiety of the amino acid analogs.  
The Binding Site for ATP or for the 3'-end of tRNA on E. 
coli IleRS 
  Several observations suggest that ADP-PL and 
tRNA
Ileox, are affinity labeling reagents for E. coli isoleucyl-
tRNA synthetase. First, incubation of either reagent with 
IleRS resulted in a rapid loss of enzyme activity. Both the 
tRNA
Ile  aminoacylation and isoleucine-dependent isotopic 
ATP-PPi exchange activities were abolished in parallel by 
the labeling. Inactivation of IleRS by either reagent most 
probably proceeded through the formation of a Schiff base 
between the aldehyde group of ADP-PL or of tRNA
Ileox and 
amino groups of the protein. Second, the stoichiometries of 
labeling of IleRS by ADP-PL or tRNA
Ileox corresponded to 
1 mol of reagent incorporated per mol of enzyme, consistent 
with the 1:1 IleRS:ATP or IleRS:tRNA
Ile active 
stoichiometries. Third, in the case of ADP-PL-labeling of 
IleRS, enzyme inactivation showed saturation behavior with 
respect to the reagent concentration, indicating that ADP-PL 
binds reversibly to the enzyme, prior to the covalent bond 
formation.  
  The plot of the fraction of inactivated IleRS versus in-
creasing reagent concentrations indicated a half-effect con-
centration of ADP-PL in the inactivation process of about 
0.17 mM, suggesting that the affinity of ADP-PL is compa-
rable to that of ATP (Kd = 0.176 mM) [31]. Finally, intact 
tRNA
Ile  or MgATP protected IleRS from inactivation by 
tRNA
Ileox, while incubation of the synthetase with MgATP 
prevented enzyme inactivation and labeling by ADP-PL. 
Altogether, these results suggest that labeling of IleRS by 
ADP-PL or by the oxidized 3'-adenosine of tRNA
Ile occurs 
specifically at the enzyme active centre. 
  The chymotryptic digestion of the [
14C]tRNA
Ileox-labeled 
IleRS yielded a unique 
603SKSIGN
608 labeled peptide in the 
primary structure of the synthetase, with the 3'-oxidized 
adenosine covalently attached to Lys-604. In the case of 
ADP-PL-labeling of IleRS, the labeled residues were Lys-
601 (fragment [601-604]) and Lys-604 (fragment [602-618]) 
(Fig. 2). Thus, altogether, the oxidized 3'-end of tRNA
Ile and 
the pyridoxal moiety of the ATP analog ADP-PL react with 
lysines 601 and 604 of the consensus sequence 
601KMSKS
605. This motif was first discovered at the active 
centre of E. coli MetRS, as a consequence of affinity label-
ing studies [3, 4, 6]. In fact, lysine-335 of the 
332KMSKS
336 
sequence in E. coli MetRS was identified as the residue ma-
jorily labeled by the oxidized 3'-adenosine of tRNA
fMet. It 
was proposed that Lys-335 could serve as a ligand for the 
CCA arm of tRNA through electrostatic interactions between 
a phosphate group of the nucleic acid and the -amino group 
[23]. Later on, Lys-335 in MetRS was found affinity labeled 
by the ATP analog adenosine triphosphopyridoxal (ATP-
PL), suggesting that this residue might contact and help ori-
entate the -phosphate of bound ATP in such a way as to 
facilitate pyrophosphate liberation as well [7]. Finally, Lys-
335 was shown by site-directed mutagenesis to be involved 
through interaction with the -phosphate of ATP in the stabi-
lization of the transition state during the synthesis of me-
thionyl-adenylate [32]. Similarly, Lys-604 of IleRS may 
serve either to guide the tRNA CCA arm or to help adenylate 
formation by interacting with the phosphate chain of the 
ATP substrate. 
  This is most probable since, as already discussed, the 
binding site for the CCA arm of tRNA might be close to the 
site for the formation of aminoacyl-adenylate, since the 3'-
end of tRNA has to react with the anhydride bond of the en-
zyme-bound aminoacyl-adenylate. 
  It should be noted that, Lys-604 of E. coli IleRS and the 
corresponding Lys-335 of E. coli MetRS are strictly con-
served in the IleRS (Fig. 10) and MetRS families [33], re-
spectively, as well as in the so called class 1 aminoacyl-
tRNA synthetases, as expected for residues involved in the 
stabilization of the transition state. 
  Since the covalent binding of the histidine-specific rea-
gent DEPC to His-591 and His-905 of E. coli IRS, was ac-
companied by enzyme activity loss, it is likely that modifica-
tion of His-591 situated at only a ten-residue distance from 
lysines-601 and -604 (Fig. 10) might be responsible for a 
steric hindrance which prevents the access of substrates to 
the catalytic site. 
The Binding Site for L-isoleucine or for Non Cognate 
Amino Acids on E. coli IleRS 
  In the double-sieve editing mechanism proposed by 
Fersht [13, 14, 34], amino acids that are smaller than the 
correct one might be activated to the adenylated form, in the 
active site of a given synthetase, while amino acids larger 
than the cognate might be rejected. In support of this hy-
pothesis, IleRS was previously shown to activate both iso-
leucine and valine to their adenylated form, while this syn-
thetase could not efficiently misactivate methionine or 
leucine [35]. 
  On the other hand, the double-sieve mechanism supposes 
that the products of misactivation of amino acids that are 
smaller than the correct one might be accepted in the editing 
site of the synthetase, while the cognate aminoacyl adenylate 
would be rejected from this site, in order to prevent its hy-
drolysis.  36    The Open Biochemistry Journal, 2009, Volume 3  Baouz et al. 
  Interestingly, in the report by Nureki et al. [15], the crys-
tal structure of IleRS from Thermus thermophilus solved at a 
2.5 Å resolution shows two catalytic sites, one for aminoacy-
lation with the substrate isoleucine, and one for editing of 
misactivated valine.  
  Actually, the substrate analog IBMK was found cova-
lently attached to Cys-462 and Cys-718, in the primary struc-
ture of E. coli IleRS. Cys-462 was previously identified as 
the target of IBMK at the active center of E. coli IleRS [36]. 
The present study therefore confirms these reports, and at the 
same time designate Cys-462 as the binding site for L-
isoleucine and/or the synthetic site where isoleucyl adenylate 
formation takes place. 
  With the exception of His-332 (or His-337), which was 
found labeled only by VBMK, the reactive analogs of L-
valine and L-norleucine, two amino acids chemically similar 
to L-isoleucine were covalently attached to a set of four resi-
dues (His-394, Cys-462, His-478 and Cys-718), two of 
which (Cys-462 and His-478) belong to fragment [452-480] 
in the amino acid binding domain of the synthetase. Labeling 
of Cys-462 by VBMK and NleBMK might reflect that they 
are comparable in size or smaller than the substrate iso-
leucine, and that, consequently, they are well fitted to the 
isoleucine binding site, in agreement with the double-sieve 
editing mechanism [13, 14, 34]. The fact that the bro-
momethyl ketone derivative of phenylalanine which is larger 
than isoleucine could not react with Cys-462 suggests that 
this reagent which is larger than IBMK, is not in proximity 
of binding with Cys-462 of the isoleucine-binding site on E. 
coli IleRS, in agreement with the double-sieve hypothesis of 
Fersht [13, 14, 34].  
  Therefore, inactivation of IleRS by FBMK might be ac-
counted for, by the covalent attachment of the reagent to 
His-478 which prevents the access of substrates to Cys-462 
of the active site. 
  All the used bromomethyl ketone derivatives of non cog-
nate amino acids (VBMK, NleBMK and FBMK) labeled in 
common His-394 (fragment [325-394]) in the editing domain 
of E. coli IleRS. In addition, VBMK specifically labeled His-
332 (or His-337) in this domain (Fig. 10). Labeling of His-
332 (or His-337) by VBMK but not by IBMK, NleBMK or 
FBMK might be explained as follows: (i) valine (Van der 
Waals volume : 105 Å
3) is smaller than the substrate iso-
leucine (Van der Waals volume : 124 Å
3), so that its product 
of misactivation, or the reactive analog thereof (namely 
VBMK) would be accepted in the editing site of the syn-
thetase, as proposed by the double-sieve mechanism; (ii) in 
contrast, the adenylate form of the cognate isoleucine or of 
larger non cognate amino acids as well as their analogs 
(IBMK, NleBMK or FBMK) would be rejected from this 
site.  
  In conclusion, the fact that VBMK, NleBMK and FBMK 
label each Cys-462 and/or His-478, in the isoleucine-binding 
domain on one hand, and His-332 (or His-337) and/or His-
394 in the editing site on the other hand, might be the reflect 
of the existence of two binding sites for non cognate amino 
acids on IleRS, in agreement with the reports by Nureki et 
al. [15] and Silvian et al. [16] for IleRS from T. thermophi-
lus and S. aureus.  
The Editing Site of E. coli IleRS 
  Comparison of fragment [322-397] with IleRS amino 
acid sequences (Fig. 10) revealed that His-332 is strictly 
conserved, while the neighbouring His-337 is only weakly 
conserved in these synthetases. By contrast, His-394 is not 
conserved at all in the IleRS family. These results suggest 
that histidines-332 and -337 might be of functional signifi-
cance in the IleRS family. 
  Mutational analysis of the E. coli IleRS editing active site 
has demonstrated a crucial role for His-332 in the hydrolytic 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (10). Alignment of amino acid sequences of IleRS from different origins, around the identified labeled residues of E. coli IleRS. 
The labeled amino acid residues covalently attached to the reactive substrate analogs used in this study are numbered (in bold) according to 
the numbering of the corrected IleRS amino acid sequence from E. coli reported here. Alignment of amino acid sequences of IleRS from 
Staphylococcus aureus (Sa), Thermus thermophilus (Tt) and Homo sapiens (Hs) with that of the same synthetase from E. coli around the 
identified labeled residues was achieved with CLUSTAL. Asteriks indicate identical residues, double dots and single dots indicate respec-
tively highly and weakly conserved residues.  Binding Site for tRNA
Ile, ATP or L-Ile, and Editing Active Site  The Open Biochemistry Journal, 2009, Volume 3    37 
editing activity of the enzyme [37]. An H332A mutant IleRS 
from  E. coli, referred to as H333A in Hendrickson et al. 
[37], was shown to exhibit the following properties: (i) 
H333A IleRS edites isoleucine, because it stimulates 
tRNA
Ile-dependent ATP hydrolysis in the presence of iso-
leucine; (ii) H333A IleRS deacylates Val-tRNA
Ile and Ile-
tRNA
Ile at similar rates comparable to that of the wild-type 
enzyme with Val-tRNA
Ile as substrate; (iii) both activated 
isoleucine and valine, in the form of their respective adeny-
lates, are translocated at similar rates by H333A from the 
active site to the editing center of the enzyme. These results 
suggest that H333A IleRS is altered in amino acid specificity 
for posttransfer editing. Affinity labeling of His-332 of IleRS 
by the bromomethyl ketone derivative of non cognate valine 
directed toward the editing active site is in agreement with 
previous work carried out with the site directed mutagenesis 
approach [37].  
  In a previous work, we have used affinity labeling [12] 
and protein modification [38] studies to identify amino acid 
residues at the synthetic and the hydrolytic editing active 
sites on E. coli ValRS. Among the amino acid residues of the 
editing active site of this synthetase, Lys-277, a residue 
strictly conserved from bacteria to human, corresponds to 
His-332 of E. coli IleRS [38] which plays a crucial role in 
editing ([37] and this work). Lys-277 of E. coli ValRS was 
also shown by site-directed mutagenesis, to be involved in 
the editing activity. Indeed, a point Lys277Ala (K277A) mu-
tation yielded a mutant E. coli ValRS that presented the fol-
lowing properties: (i) the K277A mutant exhibited a post-
transfer Thr-tRNA
Val rate significantly lower than that ob-
served for the wild-type enzyme; (ii) the K277A substitution 
altered amino acid discrimination in the editing site, result-
ing in hydrolysis of the correctly charged cognate Val-
tRNA
Val ; (iii) significant amounts of mischarged Thr-
tRNA
Val were produced by the K277A mutant, and not by 
the wild-type ValRS. 
  Primary structure alignment of the conserved editing re-
gion within the CP1 domain of IleRS, ValRS and LeuRS, 
reveals that His-332 of E. coli IleRS and the corresponding 
Lys-277 of E. coli ValRS, match with His-319 of T. thermo-
philus IleRS and with Lys-270 of T. thermophilus ValRS 
[38]. Moreover, in the tRNA-complexed T. thermophilus 
IleRS [15] and ValRS [39] 3-D structures, the editing do-
main CP1 containing His-319 (IleRS) and Lys-270 (ValRS), 
is arranged in a similar position. Thus, His-332 and His-319 
of IleRS from E. coli and T. thermophilus, respectively, as 
well as Lys-277 and Lys-270 of ValRS from E. coli and T. 
thermophilus, respectively, which play a crucial role in edit-
ing in the CP1 domain, are located at similar positions in the 
amino acid sequences [38] and in the 3-D structures of these 
synthetases [15, 39].  
  The involvement of nucleophiles in the CP1 editing do-
main of the aminoacyl-tRNA synthetases which are con-
cerned with editing has been extensively discussed [37-42]. 
However, their precise role in the editing active site remains 
to be elucidated. For example, in the crystal structure of Il-
eRS from Thermus thermophilus solved at a 2.5 angstroms 
resolution, six residues (Thr-228, Thr-229, Thr-230, Thr-
233, Asn-237 and His-319) are located in close proximity, in 
a way that is reminiscent of the catalytic triads of hydrolases 
[15]. However, the nucleophile His-319 of Thermus thermo-
philus IleRS is not conserved in the ValRS and LeuRS 
amino acid sequences, suggesting that the involvement of a 
mechanism analogous to the charge relay system in the edit-
ing site of the ValRS, IleRS and LeuRS families is less prob-
able. On the bases of the data of the present work on Es-
cherichia coli IleRS, and of the qualitative comparative la-
beling of Escherichia coli ValRS with reactive amino acids 
analogs [12, 38], we propose that the role of nucleophilic 
residues in the editing active site of the synthetases consists 
of merely helping to deprotonate the catalytic editing resi-
dues, in order to make them capable of attacking the car-
bonyl group of the ester of misactivated or misacylated non 
cognate amino acids. This hypothesis is supported by the 
observation by Edsall and Wyman [43], that situation of a 
nucleophile at a two-residue distance from another one may 
increase the nucleophilic character of each of them, by low-
ering the pKa values by up to 2 pH units. The nucleophilic 
attack resulting in the hydrolysis of the ester bond might 
insure an accurate translation process, by preventing misin-
corporation of non cognate amino acids into proteins. Fol-
lowing this nucleophilic attack, the covalent bond formed 
between the catalytic editing residues and the rejected non 
cognate amino acids might be difficult to detect with current 
analytical biochemistry tools because of the low mass of 
those amino acid adducts with regard to the whole enzymes 
masses. Work is in progress, with new generation mass spec-
trometry equipments, to detect such post-editing covalent 
protein modifications.  
ABBREVIATIONS 
Hepes: N-(2-hydroxyethyl)piperazine-N’-2-ethanesulfonic 
acid; BMK: bromomethyl ketone derivative of amino acids; 
tRNAox or tRNA dialdehyde: tRNA with the 3'-terminal cis-
diol group oxidized by sodium periodate to a dialdehyde 
group; tRNAox-red: tRNAox reduced with sodium borohy-
dride; ADP-PL: adenosine diphosphopyridoxal (or pyridoxal 
5'-diphospho-5'-adenosine); DEPC: diethylpyrocarbonate; 
MALDI-MS : matrix assisted laser desorption-ionisation 
mass spectrometry; PSD : post source decay; aminoacyl-
tRNA synthetases are abbreviated as a three-letter code of 
their specific amino acid followed by RS; amino acid resi-
dues are abbreviated as the one- or three-letter codes. 
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